Becker's Hospital Review | Healthcare News & Analysis

Author's posts

10 top reasons for hospitalization for older adults

Sepsis ranked as the most common reason for hospitalization among older adults, a KFF report found.

Pennsylvania system shifts outpatient pharmacy to hospital lobby

Independence Health System has moved a hospital outpatient pharmacy “front and center.” 

NYU Langone hospital nurses give strike notice

The Federation of Nurses/United Federation of Teachers has issueda 10-day notice of intent to strike at NYU Langone Hospital-Brooklyn in New York City.

California hospital expands service lines

Mad River Community Hospital in Arcata, Calif., will begin offering home health services and plans to open two outpatient pediatric clinics this spring. 

Philips, Mass General Brigham join forces to modernize patient data use

Philips and Somerville, Mass.-based Mass General Brigham have entered a partnership to enhance how patient data is collected and used in real time.

CHS CFO expects financial planning system to save up to $60M in 2025

Franklin, Tenn.-based Community Health Systems has completed the implementation of Oracle Health’s enterprise resource planning system, which is expected to generate up to $60 million in savings for the health system in 2025, executives said during the…

Dr. Oz commits to divesting from UnitedHealth, HCA if confirmed as CMS leader

President Donald Trump’s nominee for CMS administrator, Mehmet Oz, MD, has pledged to divest from multiple healthcare companies if confirmed to lead the agency. 

Fred Hutch Cancer Center to invest $13.5M in cybersecurity after hack

Seattle-based Fred Hutch Cancer Center plans to make $13.5 million in cybersecurity improvements as part of a settlement agreement over a 2023 data breach.

Epic plans big expansion

Epic plans to grow its conference center space to meet the needs of its expanding annual Users Group Meeting, the Wisconsin State Journal reported Feb. 20.

FDA approves generic cancer treatment for 2026 availability

The FDA has approved a generic version of lenalidomide, a drug used to treat multiple myeloma and myelodysplastic syndromes, with availability set for Jan. 31, 2026.